SPIRITUS MUNDI PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.75 GBX | -.--% |
|
-.--% | -.--% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 2.71M 216M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
| Net cash position 2022 | 942K 74.85M | Net cash position 2023 | 499K 39.64M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-2.52
x | P/E ratio 2023 |
-5.04
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.69% |
More Fundamentals
* Assessed data
More news
Current year
3.25
3.75
1 year
2.009.40
3 years
1.639.40
5 years
1.639.40
10 years
1.639.40
| Members of the board | Title | Age | Since |
|---|---|---|---|
Timothy Metcalfe
BRD | Director/Board Member | 52 | 31/03/23 |
| Director/Board Member | - | 07/07/22 | |
Simon Winson Ng
BRD | Director/Board Member | 59 | - |
Spiritus Mundi PLC is a United Kingdom-based special purpose acquisition company (SPAC). The Company is formed to seek acquisition opportunities in the healthcare services sector focusing primarily on pathology and laboratory testing, clinical diagnostics, and digital health. The Company seek acquisition targets in Europe and Asia in the clinical diagnostics sector to include clinical laboratory services (clinical lab), clinical diagnostics (PCR and blood test), and digital health (healthcare IT platform). The Company neither engaged in any operations nor generated any revenues.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 2.32M | |
| +173.89% | 6.55B | |
| +5.57% | 1.05B | |
| +2.29% | 983M | |
| +41.91% | 872M | |
| +20.36% | 787M | |
| +1.72% | 664M | |
| +40.25% | 639M | |
| -.--% | 600M | |
| -2.15% | 593M |
- Stock Market
- Equities
- SPMU Stock
